| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/26/2002 | US6350786 Complexes significantly increase the bioavailability of poorly soluble therapeutically active compounds |
| 02/26/2002 | US6350785 Methods and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors |
| 02/26/2002 | US6350784 Phytochemicals, surfactant, folic acid, |
| 02/26/2002 | US6350782 Use of basic amino acids derivatives for lowering ceramide levels |
| 02/26/2002 | US6350781 Method and analgesic preparations for sustained and extended corneal analgesia with subanesthetic concentrations of lidocaine |
| 02/26/2002 | US6350780 Methods and compositions for drug delivery |
| 02/26/2002 | US6350778 Cardiovascular disorders |
| 02/26/2002 | US6350776 Synergistic, cancer |
| 02/26/2002 | US6350775 3-phenyl-furan-(5H)-2-one and dihydrofuran-2-one derivatives as antibacterial agents |
| 02/26/2002 | US6350774 Antithrombotic agents |
| 02/26/2002 | US6350773 With an antipsychotic agents |
| 02/26/2002 | US6350772 Treatment of auto-immune diseases by photochemotherapy |
| 02/26/2002 | US6350769 Gaba alpha receptors mediate inhibition of T cell responses |
| 02/26/2002 | US6350768 Combination of riluzole and of gabapentin and its use as a medicament |
| 02/26/2002 | US6350767 Growth hormone release stimulant |
| 02/26/2002 | US6350764 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
| 02/26/2002 | US6350761 Benzenamine derivatives as anti-coagulants |
| 02/26/2002 | US6350760 Substituted piperidines as melanocortin-4 receptor agonists |
| 02/26/2002 | US6350759 Dihydro- and tetrahydro-quinoline compounds |
| 02/26/2002 | US6350758 Tropane derivatives and method for their synthesis |
| 02/26/2002 | US6350757 Cns disorders; serotonergic activity on receptors of the 5-ht.sub.2 family. |
| 02/26/2002 | US6350756 Useful for treating cancer; (20s) esters with an oxyalkanoic acid; |
| 02/26/2002 | US6350752 Modulating purine derivatives such as guanosine, inosine pranobex and 4-(3-(1,6-dihydro-6-oxo-9-purin-9-yl) -1-oxopropyl)amino)benzoic acid (ait-082); inducing in vivo production of heme oxygenase to reduce blood pressure; |
| 02/26/2002 | US6350750 Quinoline and quinazoline derivatives having corticotropin releasing factor (CRF) antagonist activity |
| 02/26/2002 | US6350747 Protein serine/threonine kinase and protein tyrosine kinase enzyme inhibitors; angiogenesis inhibitors; antitumor and antiproliferative agents |
| 02/26/2002 | US6350745 Thrombin inhibitors |
| 02/26/2002 | US6350744 Pyrmidine or pyridine derivatives; antiarthritic and antiinflammatory agents; cachexia treatment; interleukin and tumor necrosis factor inhibitors |
| 02/26/2002 | US6350742 Compositions and methods for treating infections of the ear |
| 02/26/2002 | US6350739 Methods of prevention and treatment of ischemic damage |
| 02/26/2002 | US6350738 Gramnegative bactericides; fungicides, viricides; gonane derivatives with nitrogen-containing substituent(s) |
| 02/26/2002 | US6350737 Platinum complex, its preparation and therapeutic application |
| 02/26/2002 | US6350736 phenyl methoxyalaninyl phosphate derivatives of 2',3'-didehydro-2',3'-dideoxythymidine with an electron-withdrawing moiety, such as p-bromo, for enhanced hydrolysis, have increased potency without high cytotoxic activity; inhibitors of HIV reverse transcriptase; thymidine-kinase (TK)-deficient cells |
| 02/26/2002 | US6350735 Purine derivatives |
| 02/26/2002 | US6350734 Applying with non-volatile surfactant, fatty alcohol, and/or fatty ester and detectable marker to trigger immersion reflex; drying with air or heat |
| 02/26/2002 | US6350733 Aromatic derivatives substituted by a ribose, their method of preparation and application as medicine |
| 02/26/2002 | US6350598 MurD |
| 02/26/2002 | US6350479 Treating depression with alcohol extracts of tobacco |
| 02/26/2002 | US6350471 Tablet comprising core consisting of selected active ingredient and conventional excipients, and coating consisting of water-insoluble, water-permeable film-forming polymer, water-soluble polymer and plasticizer |
| 02/26/2002 | US6350469 Tablet comprising compacted mixture of methylcellulose having high viscosity and edible calcium salt selected from dibasic calcium phosphate dihydrate, calcium phosphate anhydrous, and tribasic calcium phosphate, or mixtures thereof |
| 02/26/2002 | US6350468 Double capsule for the administration of active principles in multiple therapies |
| 02/26/2002 | US6350467 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 02/26/2002 | US6350464 Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same |
| 02/26/2002 | US6350446 Polypeptides with amino acid sequences for kidney failure |
| 02/26/2002 | US6350431 Light image contrast agent with chromopores linked with polyether |
| 02/26/2002 | US6349443 Bottle/nipple cleaning device |
| 02/26/2002 | CA2329474C Continuous low-dose cytokine infusion therapy |
| 02/26/2002 | CA2284470C New crystalline form of omeprazole |
| 02/26/2002 | CA2237883C Process for the preparation of materials with a high content of long chain polyunsaturated fatty acids |
| 02/26/2002 | CA2222771C Fat based food products |
| 02/26/2002 | CA2206776C N-sulfonylindoline derivatives carrying an amide functional group, their preparation and the pharmaceutical compositions in which they are present |
| 02/26/2002 | CA2195094C Topical ophthalmic formulations containing doxepin derivatives for treating allergic eye diseases |
| 02/26/2002 | CA2178302C Indole, indazole and benzisoxazole derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 02/26/2002 | CA2170097C Thiophene compounds; process for preparing the same and pharmaceutical compositions containing them |
| 02/26/2002 | CA2163535C Inhibition of hair growth |
| 02/26/2002 | CA2160966C Piperidine derivatives; process for preparing them and compositions containing the same |
| 02/26/2002 | CA2143249C Substituted sulfonamides; process for preparing the same and pharmaceutical compositions containing them |
| 02/26/2002 | CA2128119C Benzospiroalkene derivatives, process for their preparation and pharmaceutical compositions containing them |
| 02/26/2002 | CA2081605C Complex salts of hematoporphyrin and of its derivatives, their synthesis and therapeutic agent |
| 02/26/2002 | CA2072484C Use of nadh or nadph against cancer and aids |
| 02/26/2002 | CA2063550C Azomethines agonist compounds of the histamine h3 receptor for therapeutic use, pharmaceutical compositions acting as agonists of said receptor and method of preparation |
| 02/26/2002 | CA2057048C Vitamin d analogues |
| 02/26/2002 | CA2052020C Pradimicin derivatives |
| 02/26/2002 | CA2046801C Substituted pyrroles |
| 02/26/2002 | CA2025728C Antimicrobial compositions |
| 02/26/2002 | CA2024672C Indole, benzofuran,and benzothiophene containing lipoxygenase inhibiting compounds |
| 02/26/2002 | CA2012978C Treatment of hepatic diseases using fk 506 and related compounds |
| 02/26/2002 | CA2006717C Antibacterial anti-plaque oral composition mouthwash or liquid dentifrice |
| 02/22/2002 | WO2001012166A2 Improved treatment for acute physical insult to the central nervous system |
| 02/22/2002 | CA2419845A1 Improved treatment for acute physical insult to the central nervous system |
| 02/21/2002 | WO2002014536A2 Odulating multiple lineage kinase proteins |
| 02/21/2002 | WO2002014529A1 Curvularol and process for preparation of the same |
| 02/21/2002 | WO2002014522A1 Pyruvate:nadp+ oxidoreductase and uses thereof |
| 02/21/2002 | WO2002014513A1 Use of polypeptide |
| 02/21/2002 | WO2002014511A2 Regulation of human p2y1-like g protein-coupled receptor |
| 02/21/2002 | WO2002014477A2 Bioavailable composition of natural and synthetic hca |
| 02/21/2002 | WO2002014464A2 Plant-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections |
| 02/21/2002 | WO2002014362A2 A hepatitis c virus non-structural ns3/4a fusion gene |
| 02/21/2002 | WO2002014357A2 Use of gadd34 or pcna polypeptides in the treatment of cerebral ischaemic damage |
| 02/21/2002 | WO2002014343A1 Bufadienolide derivatives and use as immunosuppressive, antiinflammatory and analgesic agents |
| 02/21/2002 | WO2002014342A1 Steroid derived antibiotics |
| 02/21/2002 | WO2002014323A2 Polymorphs of an epothilone analog |
| 02/21/2002 | WO2002014321A1 Use of stat-6 inhibitors as therapeutic agents |
| 02/21/2002 | WO2002014319A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 02/21/2002 | WO2002014317A2 Substituted pyrazoles |
| 02/21/2002 | WO2002014316A1 Process for the preparation of imidazopyridines |
| 02/21/2002 | WO2002014315A2 Substituted pyrazoles |
| 02/21/2002 | WO2002014314A2 Substituted pyrazoles |
| 02/21/2002 | WO2002014313A2 Novel beta-amyloid inhibitors, method for producing the same and the use thereof as medicaments |
| 02/21/2002 | WO2002014312A1 Tetrazolyl-phenyl acetamide glucokinase activators |
| 02/21/2002 | WO2002014311A2 Urea compounds and methods of uses |
| 02/21/2002 | WO2002014306A1 Process for the preparation of imidazopyridines |
| 02/21/2002 | WO2002014288A1 Use of triazinetrione sulfones for combating coccidiosis |
| 02/21/2002 | WO2002014285A1 Substituted imidazoles as tafia inhibitors |
| 02/21/2002 | WO2002014283A1 Processes for preparing cilostazol |
| 02/21/2002 | WO2002014282A1 2-aminopyridine compounds and use thereof as drugs |
| 02/21/2002 | WO2002014281A1 Pyridine derivatives as inhibitors of p38 |
| 02/21/2002 | WO2002014279A1 New aporphine esters and their use in therapy |
| 02/21/2002 | WO2002014277A1 Biphenylcarboxamidoisoindoline compounds, processes for the preparation of the same and intermediates for the synthesis thereof |
| 02/21/2002 | WO2002014274A1 Selective urokinase inhibitors |
| 02/21/2002 | WO2002014273A1 Indoline derivatives as 5ht2c antagonists |